2. Cardiothoracic Department, Civil Hospitals and University of Brescia, Brescia, Italy
3. Heart Center, Zürich University Hospital, University of Zürich, Zürich, Switzerland
4. Azienda Universitaria Ospedaliera Pisana, Pisa, Italy
5. Cardiothoracic Departement, Civil Hospitals and University of Brescia, Brescia, Italy
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please log in to download the PDF.
Methods and results: We analysed 137 patients undergoing Mitraclip for SMR at 3 centres. SMR was classified as proportionate or disproportionate based on the median value of the ratio between effective regurgitant orifice area (EROA) and left ventricular end-diastolic volume (LVEDV). The primary end-point was a composite of cardiovascular mortality and heart failure hospitalization at 2-year follow-up. Mean age was 70±10 years, 80% were males, and median EuroSCORE II was 5.7%. No differences were observed in disproportionate compared to proportionate group except for a more severe NYHA class and their expected higher EROA and lower LVEDV. Number of clips deployed, device success and procedural success were similar between the two groups. Residual mitral regurgitation (MR)>1+ at 30-day was more common among patients with EROA>0.42 cm2 compared to those with EROA≤0.42 cm2 (81.3% vs. 58%; p=0.004). Cumulative incidence and relative risk of primary end-point was independent from any echocardiographic parameter, including the presence of disproportionate SMR. The only independent predictors of clinical events were EuroSCORE II>8%, NYHA class and residual MR>1+ at 30-day.
Conclusions: Echocardiographic parameters, including the EROA/LVEDV ratio, have not independent prognostic value in patients undergoing MitraClip. High surgical risk, advanced symptoms and non-optimal MR reduction increase the relative risk of 2-year clinical events.
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com